Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

[1]  H. Gunthard,et al.  Update of the Drug Resistance Mutations in HIV-1. , 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[2]  Gemma Navarro,et al.  Características clinicoepidemiológicas y tendencias en el tratamiento antirretroviral de una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana. Cohorte PISCIS , 2005 .

[3]  D. Richman,et al.  Update of the Drug Resistance Mutations in HIV-1: 2005. , 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[4]  T. Pumarola,et al.  Avances en el diagnóstico y tratamiento de la infección aguda por el VIH-1 , 2004 .

[5]  E. Rosenberg,et al.  Limited Durability of Viral Control following Treated Acute HIV Infection , 2004, PLoS medicine.

[6]  C. Rouzioux,et al.  Recent changes in the management of primary HIV‐1 infection: results from the French PRIMO cohort , 2004, HIV medicine.

[7]  J. Eron,et al.  Acute HIV revisited: new opportunities for treatment and prevention. , 2004, The Journal of clinical investigation.

[8]  E. Rosenberg,et al.  Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? , 2004, AIDS.

[9]  William C Miller,et al.  Frequent detection of acute primary HIV infection in men in Malawi , 2004, AIDS.

[10]  K. Freedberg,et al.  Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Voirin,et al.  Incubation and Duration of Specific Symptoms at Acute Retroviral Syndrome as Independent Predictors of Progression to AIDS , 2003, Journal of acquired immune deficiency syndromes.

[12]  P. Vanhems,et al.  Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age. , 2002, Journal of acquired immune deficiency syndromes.

[13]  Christopher D Pilcher,et al.  Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. , 2002, JAMA.

[14]  J. Baeten,et al.  Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Szabo,et al.  Unusual presentations of primary human immunodeficiency virus infection. , 2002, AIDS patient care and STDs.

[16]  E. Rosenberg,et al.  Use of laboratory tests and clinical symptoms for identification of primary HIV infection , 2002, AIDS.

[17]  S. Self,et al.  Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. , 2001, The Journal of infectious diseases.

[18]  Susan Little,et al.  Diagnosis of Primary HIV-1 Infection , 2001, Annals of Internal Medicine.

[19]  Conway,et al.  Comparison of Clinical Features of Acute HIV-1 Infection in Patients Infected Sexually or Through Injection Drug Use. , 2000, Journal of acquired immune deficiency syndromes.

[20]  P. Vanhems,et al.  Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. , 2000, The Journal of infectious diseases.

[21]  L. Papagno,et al.  Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Easterbrook,et al.  Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Mandaliya,et al.  Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  T V Perneger,et al.  Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia , 2000, AIDS.

[25]  P. Vanhems,et al.  Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. , 1999, Journal of acquired immune deficiency syndromes.

[26]  J. Lisziewicz,et al.  Control of HIV despite the discontinuation of antiretroviral therapy. , 1999, The New England journal of medicine.

[27]  J. Moore,et al.  The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. , 1999, The Journal of infectious diseases.

[28]  R. Brookmeyer,et al.  Risk factors and clinical presentation of acute primary HIV infection in India. , 1997, JAMA.

[29]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[30]  P. Vanhems,et al.  Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[32]  D. Hawkins,et al.  A controlled trial of zidovudine in primary human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[33]  D. Bucquet,et al.  Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group. , 1995, The Journal of infectious diseases.

[34]  J. Peña,et al.  Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. , 1991, Reviews of infectious diseases.

[35]  J. Gold,et al.  ACUTE AIDS RETROVIRUS INFECTION Definition of a Clinical Illness Associated with Seroconversion , 1985, The Lancet.

[36]  P. Noone,et al.  AMIKACIN RESISTANCE DEVELOPING IN PATIENT WITH PSEUDOMONAS ÆRUGINOSA BRONCHOPNEUMONIA , 1976, The Lancet.

[37]  M. McElrath,et al.  Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. , 2000, The Journal of infectious diseases.

[38]  R. Read,et al.  Prolonged cryptosporidiosis during primary HIV infection. , 1995, The Journal of infection.